315 related articles for article (PubMed ID: 25301716)
1. A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy.
Cojutti P; Scarparo C; Sartor A; Coato P; Rigoli R; Pea F
Diagn Microbiol Infect Dis; 2015 Jan; 81(1):53-6. PubMed ID: 25301716
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.
Kao TM; Wang JT; Weng CM; Chen YC; Chang SC
J Microbiol Immunol Infect; 2011 Oct; 44(5):346-51. PubMed ID: 21524980
[TBL] [Abstract][Full Text] [Related]
3. [In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates to vancomycin, teicoplanin, linezolide and daptomycin].
Celikbilek N; Ozdem B; Gürelik FC; Güvenman S; Güner HR; Açıkgöz ZC
Mikrobiyol Bul; 2011 Jul; 45(3):512-8. PubMed ID: 21935784
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of vancomycin, teicoplanin, linezolide and tigecycline susceptibilities of nosocomial methicillin-resistant Staphylococcus strains by E-test].
Pelitli TS; Cesur S; Kınıklı S; Irmak H; Demiröz AP; Karakoç E
Mikrobiyol Bul; 2011 Oct; 45(4):758-61. PubMed ID: 22090309
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of antibiotic susceptibilities and VISA-VRSA rates among MRSA strains isolated from hospitalized patients in intensive care units of hospitals in seven provinces of Turkey].
Cesur S; Irmak H; Simşek H; Cöplü N; Kılıç H; Arslan U; Bayramoğlu G; Baysan BO; Gülay Z; Hoşoğlu S; Berktaş M; Gencer S; Demiröz AP; Esen B; Karabiber N; Aydın F; Yalçın AN
Mikrobiyol Bul; 2012 Jul; 46(3):352-8. PubMed ID: 22951647
[TBL] [Abstract][Full Text] [Related]
6. Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.
Salem AH; Zhanel GG; Ibrahim SA; Noreddin AM
Clin Exp Pharmacol Physiol; 2014 Jun; 41(6):437-43. PubMed ID: 24341387
[TBL] [Abstract][Full Text] [Related]
7. Comparative activity of oritavancin against meticillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates from Geneva University Hospital.
Vaudaux P; Huggler E; Arhin FF; Moeck G; Renzoni A; Lew DP
Int J Antimicrob Agents; 2009 Dec; 34(6):540-3. PubMed ID: 19744838
[TBL] [Abstract][Full Text] [Related]
8. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
Huang YT; Liao CH; Teng LJ; Hsueh PR
Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671
[TBL] [Abstract][Full Text] [Related]
9. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study of the susceptibility to daptomycin and other antimicrobials against Staphylococcus spp. resistant to methicillin and Enterococcus spp. using Wider, E-test, and microdilution methods].
Gómez-Garcés JL; López-Fabal F; Burillo A; Gil Y
Rev Esp Quimioter; 2010 Jun; 23(2):87-92. PubMed ID: 20559607
[TBL] [Abstract][Full Text] [Related]
11. [Staphylococcus aureus and antibiotic resistance].
Sancak B
Mikrobiyol Bul; 2011 Jul; 45(3):565-76. PubMed ID: 21935792
[TBL] [Abstract][Full Text] [Related]
12. Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus.
Tascini C; Flammini S; Leonildi A; Ciullo I; Tagliaferri E; Menichetti F
J Chemother; 2012 Aug; 24(4):187-90. PubMed ID: 23040680
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.
Sader HS; Jones RN; Rossi KL; Rybak MJ
J Antimicrob Chemother; 2009 Nov; 64(5):1024-8. PubMed ID: 19744978
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
Steinkraus G; White R; Friedrich L
J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
[TBL] [Abstract][Full Text] [Related]
15. Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.
Farrell DJ; Flamm RK; Sader HS; Jones RN
Int J Antimicrob Agents; 2014 Apr; 43(4):323-7. PubMed ID: 24411474
[TBL] [Abstract][Full Text] [Related]
16. Glycopeptide and daptomycin susceptibility trends among clinical isolates of methicillin-resistant Staphylococcus aureus in a tertiary care center in North India.
Singh A; Prasad KN; Rai RP; Singh SK; Rahman M; Tripathi A; Srivastava JK
J Infect Public Health; 2015; 8(4):341-5. PubMed ID: 25797814
[TBL] [Abstract][Full Text] [Related]
17. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm.
Raad I; Hanna H; Jiang Y; Dvorak T; Reitzel R; Chaiban G; Sherertz R; Hachem R
Antimicrob Agents Chemother; 2007 May; 51(5):1656-60. PubMed ID: 17353249
[TBL] [Abstract][Full Text] [Related]
18. Correlation between vancomycin MIC values and those of other agents against gram-positive bacteria among patients with bloodstream infections caused by methicillin-resistant Staphylococcus aureus.
Patel N; Lubanski P; Ferro S; Bonafede M; Harrington S; Evans A; Stellrecht K; Lodise TP
Antimicrob Agents Chemother; 2009 Dec; 53(12):5141-4. PubMed ID: 19805558
[TBL] [Abstract][Full Text] [Related]
19. [The incidence and risk factors for heterogeneous vancomycin intermediate Staphylococcus aureus].
Feng NN; Wang Q; Song YL; He LX; Zhou CM; Xie HM; Li HY
Zhonghua Nei Ke Za Zhi; 2013 Apr; 52(4):318-22. PubMed ID: 23925360
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus.
Uçkay I; Bernard L; Buzzi M; Harbarth S; François P; Huggler E; Ferry T; Schrenzel J; Renzoni A; Vaudaux P; Lew DP
Antimicrob Agents Chemother; 2012 Mar; 56(3):1258-64. PubMed ID: 22155824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
